|
|
|
|
|
|
|
|
|
|
open access - Editorial
In January 2015, based on the available data on ovarian
carcinogenesis and the safety of salpingectomy, both the American
College of Obstetricians and Gynecologists (ACOG) and
the American Cancer Society (ACS) recommended that surgeons should
discuss
the potential benefits of the prophylactic removal of
the Fallopian tubes (FTs) for permanent contraception or during
surgeries
for benign pathologies with every woman at population
risk for ovarian cancer (OC) [1, 2].
This is a potential revolution. Until the end of the 20th century, salpingectomy was considered to be an unworthy appendix
of more complex gynecological surgeries or as an “emergency” measure to treat life-threatening conditions....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.